$PDSB News

PDS Biotechnology Establishes Up To $50M At-The-Market Common Stock Offering Program

Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher

PDS Biotechnology Corp (PDSB) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...

PDS Biotechnology Q1 Earnings Call Highlights

PDS Biotechnology Corporation Q1 2026 Earnings Call Summary

PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript

PDS Biotech (NASDAQ:PDSB) Posts Narrower Q1 Loss, Pre-Market Rises Over 5%

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

PDS Biotechnology Corporation (PDSB) Q1 2026 Earnings Call Transcript

PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript

PDS Biotechnology Q1 EPS $(0.13) Beats $(0.15) Estimate

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target

Why Is PDS Biotechnology Stock Gaining Wednesday?

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

PDS Biotechnology shares are trading higher after the company announced the publication of clinical and immunological biomarker data from Stage 1 of a Phase 2 trial evaluating its tumor-targeted IL-12 immunocytokine, PDS01ADC, in the March 10, 2026 issue of Journal of Clinical Oncology Oncology Advances.

PDS Biotechnology shares are trading higher after the company announced the publication of clinical and immunological biomarker data from Stage 1 of a Phase 2 trial evaluating its tumor-targeted IL-12 immunocytokine, PDS01ADC, in the March 10, 2026 issue of Journal of Clinical Oncology Oncology Advances.

PDS Biotechnology Announces Publication Of Clinical And Immunological Biomarker Data From Stage 1 Of Phase 2 Trial Evaluating Its Tumor-Targeted IL-12 Immunocytokine, PDS01ADC, In March 10 Issue Of JCO Oncology Advances

PDS Biotechnology Corporation Q4 2025 Earnings Call Summary

PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Highlights: Financial Discipline Amid ...